The Science Team at Amagma focuses on pioneering research and development of antibody-based therapies targeting clinical dysfunctions. Comprising experts in biologics and protein biochemistry, the team conducts experiments, analyzes data, and develops innovative solutions to advance the company's mission of addressing unmet clinical needs.
View all